InvestorsHub Logo
Followers 59
Posts 11471
Boards Moderated 0
Alias Born 07/16/2006

Re: indigokid post# 17576

Thursday, 08/10/2017 4:13:38 PM

Thursday, August 10, 2017 4:13:38 PM

Post# of 20689
There has been an absolute void of discussion on why Sandoz/Momenta has not been able to compete in the enoxaparin market. Momenta's enoxaparin has turned from the initial gold mine to a absolute liability.

Will any future endeavors bee different?